Innealta Capital’s PDL BioPharma, Inc. PDLI Stock Holding History

Innealta Capital’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-50	Closed	–	–	1830
2024 Q2	$0	Buy	+50	New	–	﹤0.01%	1846

Other funds holding PDLI

Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Innealta Capital's PDLI Position: Q3 2024 in Review

Innealta Capital sold out of PDL BioPharma, Inc. (PDLI) in Q3 2024, closing a stake of 50 shares.

Innealta Capital first reported a position in PDLI in Q2 2024 and held it in 1 quarter. The position peaked at $0 in Q2 2024. 5 funds tracked by Wall St. Rank hold PDLI as of Q3 2024.

Innealta Capital reported no remaining PDL BioPharma, Inc. position as of Q3 2024 after selling out during the quarter.
Innealta Capital sold 50 PDL BioPharma, Inc. shares in Q3 2024.
Innealta Capital first reported a position in PDL BioPharma, Inc. in Q2 2024 and held it in 1 quarter.
Innealta Capital's PDL BioPharma, Inc. position peaked at $0 in Q2 2024.
5 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q3 2024.

Based on Innealta Capital's 13F filing for Q3 2024, filed 29 Oct 2024.